Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
San Francisco, California, USA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital, is offering eligible investors an investment opportunity of up to $250...
-
A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models of AML KT-253 showed combinatorial benefit with BCL-2 inhibitor venetoclax in model of...
-
CARSON CITY, NV, Dec. 06, 2022 (GLOBE NEWSWIRE) -- CECORS, INC. (OTC PINK: CEOS) ("CeCors" or the "Company"), through its wholly-owned subsidiary PsyKey Inc., an innovative wellness company, is...
-
WATERTOWN, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small...
-
Mountain View, California, Nov. 18, 2022 (GLOBE NEWSWIRE) -- SENS RESEARCH FOUNDATION (SRF) has launched its 2022 End of Year Campaign to raise funds for its research dedicated to eradicating...
-
CARSON CITY, NV, Nov. 16, 2022 (GLOBE NEWSWIRE) -- CECORS, INC. (OTC PINK: CEOS) ("CeCors" or the "Company"), through its wholly owned subsidiary PsyKey Inc., an innovative wellness company, is...
-
Park City, Utah, Nov. 15, 2022 (GLOBE NEWSWIRE) -- OCEARCH Embarks on Expedition Southbound, Bringing Unprecedented White Shark Research off the Coast of the Southeast United States White sharks...
-
WASHINGTON, DC, Nov. 15, 2022 (GLOBE NEWSWIRE) -- In 18 months, the Global Alzheimer’s Platform Foundation (GAP) recruited more than 1,000 participants to enroll in the first-ever head-to-head study...
-
Westminster, Colorado, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Advanced Space LLC., a leading space tech solutions company, announced CAPSTONE successfully completed the initial insertion maneuver into a...
-
Kymera Therapeutics Appoints Biopharmaceutical Leader Victor Sandor, M.D.C.M., to Board of Directors
WATERTOWN, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small...